Aberdeen Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.6M Sell
160,879
-46,500
-22% -$17.8M 0.1% 168
2025
Q1
$71.6M Sell
207,379
-9,222
-4% -$3.18M 0.14% 140
2024
Q4
$64.7M Sell
216,601
-64,642
-23% -$19.3M 0.12% 176
2024
Q3
$113M Sell
281,243
-1,113
-0.4% -$448K 0.21% 113
2024
Q2
$90.7M Buy
282,356
+4,604
+2% +$1.48M 0.17% 128
2024
Q1
$92.6M Buy
277,752
+16,444
+6% +$5.48M 0.18% 130
2023
Q4
$70.7M Buy
261,308
+96,889
+59% +$26.2M 0.15% 153
2023
Q3
$40.4M Buy
164,419
+7,476
+5% +$1.84M 0.1% 190
2023
Q2
$47.6M Buy
156,943
+9,719
+7% +$2.95M 0.11% 176
2023
Q1
$38.8M Buy
147,224
+9,866
+7% +$2.6M 0.1% 217
2022
Q4
$33M Buy
137,358
+5,206
+4% +$1.25M 0.09% 247
2022
Q3
$24.3M Buy
132,152
+44,928
+52% +$8.26M 0.07% 289
2022
Q2
$14.7M Buy
87,224
+4,649
+6% +$781K 0.05% 352
2022
Q1
$21M Sell
82,575
-20,708
-20% -$5.27M 0.05% 299
2021
Q4
$26.5M Sell
103,283
-11,205
-10% -$2.88M 0.06% 290
2021
Q3
$28M Buy
114,488
+3,670
+3% +$899K 0.06% 284
2021
Q2
$22.9M Sell
110,818
-3,813
-3% -$788K 0.05% 327
2021
Q1
$21.6M Buy
114,631
+6,605
+6% +$1.24M 0.05% 325
2020
Q4
$17.8M Sell
108,026
-1,588
-1% -$261K 0.04% 345
2020
Q3
$13.7M Sell
109,614
-16,364
-13% -$2.04M 0.04% 360
2020
Q2
$12.2M Sell
125,978
-10,915
-8% -$1.06M 0.03% 371
2020
Q1
$12.3M Buy
136,893
+3,665
+3% +$329K 0.04% 356
2019
Q4
$19.7M Sell
133,228
-16,053
-11% -$2.37M 0.05% 334
2019
Q3
$18M Sell
149,281
-21,964
-13% -$2.65M 0.04% 343
2019
Q2
$23.2M Buy
171,245
+24,320
+17% +$3.29M 0.05% 334
2019
Q1
$19.2M Buy
146,925
+17,224
+13% +$2.25M 0.04% 367
2018
Q4
$15.9M Buy
129,701
+16,434
+15% +$2.01M 0.04% 371
2018
Q3
$15.8M Buy
113,267
+8,677
+8% +$1.21M 0.03% 423
2018
Q2
$10.7M Buy
104,590
+14,893
+17% +$1.53M 0.02% 466
2018
Q1
$8.7M Buy
89,697
+535
+0.6% +$51.9K 0.02% 469
2017
Q4
$7.83M Sell
89,162
-32,922
-27% -$2.89M 0.02% 487
2017
Q3
$9.72M Buy
+122,084
New +$9.72M 0.02% 455